Literature DB >> 18331606

Associations with multiple pituitary hormone deficiency in patients with an ectopic posterior pituitary gland.

P G Murray1, C Hague, O Fafoula, L Patel, A L Raabe, C Cusick, C M Hall, N B Wright, R Amin, P E Clayton.   

Abstract

INTRODUCTION: The presence of an ectopic posterior pituitary gland (EPP) on magnetic resonance imaging (MRI) is associated with hypopituitarism with one or more hormone deficiencies. We aimed to identify risk factors for having multiple pituitary hormone deficiency (MPHD) compared to isolated growth hormone deficiency (IGHD) in patients with an EPP.
METHODS: In 67 patients (45 male) with an EPP on MRI, the site (hypothalamic vs. stalk) and surface area (SA) [ x (maximum diameter/2) x (maximum height/2), mm(2)] of the EPP were recorded and compared in patients with IGHD and MPHD in relation to clinical characteristics.
RESULTS: In MPHD (n = 32) compared to IGHD (n = 35) patients: age of presentation was younger (1.4 [0.1-10.7]vs. 4.0 [0.1-11.3] years, P = 0.005), major incidents during pregnancy were increased (47%vs. 20%, P = 0.02) as were admissions to a neonatal intensive care unit (NICU) (60%vs. 26%, P = 0.04), whilst EPP SA was lower (12.3 [2.4-34.6]vs. 25.7 [6.9-48.2] mm(2), P < 0.001). In patients with a hypothalamic (n = 56) compared to a stalk sited EPP (n = 11): prevalence of MPHD was greater (55%vs. 9%,P = 0.05) and EPP surface area was smaller (17.3 [2.4-48.2]vs. 25.3 [11.8-38.5] mm(2), P < 0.001). In regression analysis, after adjusting for age, presence of MPHD was associated with: major incidents during pregnancy (RR 6.8 [95%CI 1.2-37.7]), hypothalamic EPP site (RR 10.9 [1.0-123.9]) and small EPP SA (RR 2.5 [1.0-5.0] for tertiles of SA).
CONCLUSION: In patients with an EPP, adverse antenatal events, size (small) and position (hypothalamic) of the posterior pituitary gland on MRI were associated with MPHD. These findings suggest that adverse factors during pregnancy may be important for the development of an EPP.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18331606     DOI: 10.1111/j.1365-2265.2008.03236.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  7 in total

1.  Ectopic posterior pituitary causing hyperprolactinemia.

Authors:  D Iacovazzo; F Lugli; A Giampietro
Journal:  Endocrine       Date:  2012-06-26       Impact factor: 3.633

2.  A new imaging entity consistent with partial ectopic posterior pituitary gland: report of six cases.

Authors:  Marina Ybarra; Rawan Hafiz; Marie-Eve Robinson; Julia Elisabeth von Oettingen; Helen Bui; Christine Saint-Martin
Journal:  Pediatr Radiol       Date:  2019-08-30

3.  Ectopic posterior pituitary and stalk abnormality predicts severity and coexisting hormone deficiencies in patients with congenital growth hormone deficiency.

Authors:  Varsha S Jagtap; Shrikrishna V Acharya; Vijaya Sarathi; Anurag R Lila; Sweta R Budyal; Rajeev Kasaliwal; Shilpa S Sankhe; Tushar R Bandgar; Padmavathy S Menon; Nalini S Shah
Journal:  Pituitary       Date:  2012-06       Impact factor: 4.107

4.  Diagnostic pitfalls in the assessment of congenital hypopituitarism.

Authors:  Paolo Cavarzere; Paolo Biban; Rossella Gaudino; Silvia Perlini; Lorenzo Sartore; Lorenza Chini; Davide Silvagni; Franco Antoniazzi
Journal:  J Endocrinol Invest       Date:  2014-08-01       Impact factor: 4.256

5.  SCREENING OF PROP-1, LHX2 AND POU1F1 MUTATIONS IN PATIENTS WITH ECTOPIC POSTERIOR PITUITARY GLAND.

Authors:  H A Korkmaz; U Karaarslan; C Eraslan; D Atila; F Hazan; V Barışık; E S Ata; O Etlik; M Yıldız; B Ozkan
Journal:  Acta Endocrinol (Buchar)       Date:  2018 Jul-Sep       Impact factor: 0.877

6.  Hepatopathy in an adult, secondary to congenital untreated panhypopituitarism and ectopic posterior pituitary gland.

Authors:  Miguel A Valle-Murillo; Ivan Perez-Diaz
Journal:  Indian J Endocrinol Metab       Date:  2012-09

7.  Pituitary stalk interruption syndrome in 53 postpubertal patients: factors influencing the heterogeneity of its presentation.

Authors:  Luu-Ly Pham; Pierre Lemaire; Annie Harroche; Jean-Claude Souberbielle; Raja Brauner
Journal:  PLoS One       Date:  2013-01-07       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.